Skip to main content

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC

Position in BSX — Boston Scientific Corp

CIK 1632972 PLYMOUTH, MN

Position in BSX

as of Mar 31, 2026 · filed Apr 8, 2026
Position Value
$11,277,681
-$1,640,813 QoQ
Shares Held
179,724
+32.7% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2023
12 quarters on record
Voting authority Sole 4.5647517039922105.ToString("F0")% Shared 0.ToString("F0")% None 95.43524829600779.ToString("F0")%

Common Shares in BSX Over Time

Shares Held

Position Value (USD)

Derivatives in BSX

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
0
PutValue
$941,250
PutShares
15,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $292,456,726 across 40 Medical Devices names. BSX ranks #4 (3.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 BSX
Boston Scientific Corp
This page
179,724 $11,277,681

All Filings in BSX

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $941,250 15,000
2026-03-31 $11,277,681 179,724
2025-12-31 $12,918,494 135,485
2025-12-31 $1,430,250 15,000
2025-09-30 $1,464,450 15,000
2025-09-30 $11,418,023 116,952
2025-06-30 $12,432,707 115,750
2025-06-30 $1,611,150 15,000
2025-03-31 $10,593,307 105,009
2025-03-31 $1,513,200 15,000
2024-12-31 $7,159,265 80,153
2024-09-30 $13,285,484 158,538
2024-06-30 $5,472,946 71,068
2024-03-31 $4,521,983 66,024
2023-12-31 $3,441,949 59,539
2023-09-30 $3,245,510 61,468
2023-03-31 $366,619 7,328